ATE209506T1 - Polyaminosäure-träger für oligonukleotid - Google Patents

Polyaminosäure-träger für oligonukleotid

Info

Publication number
ATE209506T1
ATE209506T1 AT94927785T AT94927785T ATE209506T1 AT E209506 T1 ATE209506 T1 AT E209506T1 AT 94927785 T AT94927785 T AT 94927785T AT 94927785 T AT94927785 T AT 94927785T AT E209506 T1 ATE209506 T1 AT E209506T1
Authority
AT
Austria
Prior art keywords
oligonucleotide
carrier
polyamino acid
acid carrier
plants
Prior art date
Application number
AT94927785T
Other languages
English (en)
Inventor
Minenobu Okayama
Yosuke Suzuki
Akira Wada
Original Assignee
Hisamitsu Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co filed Critical Hisamitsu Pharmaceutical Co
Application granted granted Critical
Publication of ATE209506T1 publication Critical patent/ATE209506T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/645Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
AT94927785T 1993-09-28 1994-09-28 Polyaminosäure-träger für oligonukleotid ATE209506T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP24185393 1993-09-28
PCT/JP1994/001590 WO1995009009A1 (en) 1993-09-28 1994-09-28 Polyamino acid oligonucleotide carrier

Publications (1)

Publication Number Publication Date
ATE209506T1 true ATE209506T1 (de) 2001-12-15

Family

ID=17080488

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94927785T ATE209506T1 (de) 1993-09-28 1994-09-28 Polyaminosäure-träger für oligonukleotid

Country Status (12)

Country Link
US (1) US5912300A (de)
EP (1) EP0727223B1 (de)
JP (1) JP3289912B2 (de)
KR (1) KR100324257B1 (de)
AT (1) ATE209506T1 (de)
AU (1) AU681192B2 (de)
CA (1) CA2172974C (de)
DE (1) DE69429278T2 (de)
DK (1) DK0727223T3 (de)
ES (1) ES2163453T3 (de)
TW (1) TW380052B (de)
WO (1) WO1995009009A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0775751A3 (de) * 1995-11-22 1998-06-10 F. Hoffmann-La Roche Ag Zelltransfektion
ATE244021T1 (de) * 1996-01-17 2003-07-15 Hoffmann La Roche Transfektionskompetente moleküle
US6441025B2 (en) * 1996-03-12 2002-08-27 Pg-Txl Company, L.P. Water soluble paclitaxel derivatives
US6958148B1 (en) 1998-01-20 2005-10-25 Pericor Science, Inc. Linkage of agents to body tissue using microparticles and transglutaminase
US6919076B1 (en) 1998-01-20 2005-07-19 Pericor Science, Inc. Conjugates of agents and transglutaminase substrate linking molecules
AU770963B2 (en) * 1998-12-02 2004-03-11 I.D.M. Immuno-Designed Molecules New oligomeric conjugates liable to transfer biological molecules into cells
DE19858005B4 (de) * 1998-12-16 2007-02-08 november Aktiengesellschaft, Gesellschaft für Molekulare Medizin Synthetisches Nucleinsäure-Partikel
WO2001047496A1 (en) 1999-12-29 2001-07-05 Mixson A James Histidine copolymer and methods for using same
US7070807B2 (en) 1999-12-29 2006-07-04 Mixson A James Branched histidine copolymers and methods for using same
US7465708B2 (en) 2002-11-25 2008-12-16 Mixson A James Branched cationic copolymers and methods for antimicrobial use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5718727A (en) * 1980-07-07 1982-01-30 Teijin Ltd Reactive polymer and its preparation
US5132230A (en) * 1989-03-28 1992-07-21 Isolab, Inc. Primary standard and method of making secondary standards for calibration of glycated protein assays
JP2626654B2 (ja) * 1990-03-31 1997-07-02 科学技術振興事業団 標的指向性高分子医薬化合物及びその中間体

Also Published As

Publication number Publication date
WO1995009009A1 (en) 1995-04-06
KR960704580A (ko) 1996-10-09
EP0727223B1 (de) 2001-11-28
KR100324257B1 (ko) 2002-08-27
CA2172974C (en) 2005-07-12
ES2163453T3 (es) 2002-02-01
TW380052B (en) 2000-01-21
EP0727223A4 (de) 1998-08-12
EP0727223A1 (de) 1996-08-21
CA2172974A1 (en) 1995-04-06
AU7706994A (en) 1995-04-18
DE69429278D1 (de) 2002-01-10
US5912300A (en) 1999-06-15
AU681192B2 (en) 1997-08-21
JP3289912B2 (ja) 2002-06-10
DK0727223T3 (da) 2002-02-11
DE69429278T2 (de) 2002-07-11

Similar Documents

Publication Publication Date Title
ATE209506T1 (de) Polyaminosäure-träger für oligonukleotid
EP0827410A4 (de) Verfahren zür einführung und expression von genen in tierischen zellen
DE69624801D1 (de) Stabile arzneistoffabgabekomplexe mit lipiden und verfahren zu deren herstellung
TR199901332T2 (xx) Amino asit deasetilazlar� kodlayan genler, izolasyonu ve kullan�m�.
RU94040177A (ru) Нуклеиновая кислота, химерный ген, трансформирующий носитель, растительная клетка, растение или его предок, способ получения растения
MY113586A (en) Aylsulfonylamino hydroxamic acid derivatives
HUP0203347A2 (hu) Hibrid téli olajrepce és eljárások előállítására
ATE255639T1 (de) Auf fungus reagierendes chimaeres gen
ATE151076T1 (de) Oligonucleotid-analoge mit terminalen 3'-3'-bzw. 5'-5'-internucleotidverknüpfungen
ES2054708T3 (es) Gen de resistencia frente a fosfinotricina, activo en plantas y su utilizacion.
CA2171618A1 (en) Purine nucleoside phosphorylase gene therapy for human malignancy
BR9905776A (pt) Processo de fermentação para a preparação de ácido d-pantotênico através da amplificação do gene pand em microorganismos
PT86863A (pt) Stable gene amplification in chromosomal dna of prokaryotic microorganisms
GR3006561T3 (de)
EP2199392A3 (de) Genetische veränderung von somatischen zellen und deren verwendungen
DE3675481D1 (de) Verbindungen, enthaltend eine oligonukleotide sequenz, gebunden an eine interkalierungsverbindung und an eine aktivierbare chemische verbindung, ihre synthese und verwendungen als artifizielle sequenzspezifische nuklease.
CY1106041T1 (el) Καινοφανης συλλεκτινη
DK1175489T3 (da) Oligonukleotider indeholdende en antisense-sekvens stabiliseret af en sekundær struktur og farmaceutiske præparater indeholdende disse oligonukleotider
DK0998501T3 (da) Kationiske polymerer, komplekser, som associerer de kationiske polymerer og terapeutisk aktive substanser, der omfatter mindst én negativ ladning, især nukleinsyrer, og anvendelse i genterapi
RU94046200A (ru) Последовательности днк, производные последовательностей днк, плазмиды, способ применения последовательностей, способ применения плазмид, трансгенные растения
KR940007056A (ko) 단백질과 이 단백질을 코우드하는 dna 및 이 단백질의 제조방법
MX9700560A (es) Metodo de uso de integrasa retroviral negativa transdominante en el tratamiento de infecciones retrovirales.
ES2145819T3 (es) Interleucina 6 mutante de actividad biologica mejorada con relacion a la de la interleucina 6 salvaje.
Iordan et al. Effect of vitamin B sub (12) on DNA synthesis of Propionibacterium
ES2049760T3 (es) Procedimiento para la produccion de acido piruvico por fermentacion.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee